Experience of Using Stereotactic Ablative Radiotherapy for Radical Treatment of Low and Intermediate Risk Prostate Cancer. Вопр. онкол. 2024, 70 (2), 292-298. https://doi.org/10.37469/0507-3758-2024-70-2-292-298.